- Manufacturing outlook expected to edge higher from March record.
- New Orders Index building on the best nine months in four decades.
- First quarter Retail Sales boost manufacturing optimism.
- Manufacturing PMI is an indicator for overall economic health.
- Markets will note but not trade on these PMI figures.
The US manufacturing sector looks to continue its boisterous ways with executive sentiment and new business setting records as the US economy powers out of the pandemic.
The Purchasing Managers’s Index (PMI) from the Institute for Supply Management is forecast to rise to 65 in April from its 38-year high of 64.7 in March. The Prices Paid Index will dip to 85 from 85.6. New Orders were 68 and the Employment Index was 59.6 in March.
The production sector has been on a strong upswing for four months.
The 61.2 average of the last four months for the Manufacturing Purchasing Managers' Index from the Institute for Supply Management is the highest since March 1984. New Orders have averaged 64.7 for the nine months from July through March and that is the highest three-quarters of a year since August 2004.
Employment has lagged the general improvement in the manufacturing indexes but the three month average of 55.3 is the best of the pandemic era.
The New Orders Index is the best indicator of the flood of business that has buoyed the factory sector and prompted the near-historic levels of optimism.
Originating in the spate of delayed orders in the second half of last year after the collapse in March, April and May, the factory order book was given a second fillip by the surge of Retail Sales in the first quarter.
Aided by the two stimulus awards of $600 in January and $1400 in March and the red-hot job market, US consumers boosted Retail Sales by 4.90% in the first quarter. The Control Group category that enters the GDP calculation, was scarcely less active, averaging 4.07% for the quarter. Consumer spending accounts for about 70% of US economic activity, with these sales figures it is hardly surprising factory managers are optimistic.
The manufacturing sector, though only about 15% of US GDP is considered an indicator for the welfare of the overall economy.
The waning of the pandemic has not only released a tide of business delayed by last year's lockdowns, but consumers are spending in relief and enjoyment. Congress will pass some version of the Biden administration’s infrastructure bill adding to the flood of spending coming out of the capitol.
That era of good feeling is likely to last well into the second half as even the die-hard centers of restriction like New York City end their business inhibitions by July 1.
Managers have every reason to expect the good times to last until the end of the year.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.